Aerie Pharmaceuticals, Inc., a biotechnology company, engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of ophthalmic diseases. It focuses on the development of products for the pharmaceutical treatment of glaucoma. The Company’s lead product candidate, AR-13324, is the first of a new dual action drug class that reduces the eye’s fluid inflow while also increasing fluid outflow through the trabecular meshwork, which is the eye’s main fluid drain, all in a highly effective single drop per day. Aerie’s PG324 fixed combination of AR-13324 with latanoprost is a first-in-class glaucoma therapy to lower intraocular pressure by reducing fluid inflow while also opening both of the eye’s fluid drains. This product candidate offers the convenience of two drugs in one eye drop.

Employee Rating

5.0More
TypePublic
HQIrvine, US
Founded2005
Size (employees)95 (est)+36%
Websiteaeriepharma.com
Aerie Pharmaceuticals was founded in 2005 and is headquartered in Irvine, US
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

Aerie Pharmaceuticals Office Locations

Aerie Pharmaceuticals has offices in Irvine, Dublin, Durham and Bedminster Township
Irvine, (HQ)
2030 Main St
Bedminster Township,
135 US-206
Durham,
4301 Emperor Blvd
Dublin,
28-32 Pembroke Street
Show all (4)
Report incorrect company information

Aerie Pharmaceuticals Financials and Metrics

Aerie Pharmaceuticals Revenue

USD

Revenue (Q3, 2018)

7.3m

Gross profit (Q3, 2018)

7.1m

Gross profit margin (Q3, 2018), %

97.2%

Net income (Q3, 2018)

(85.4m)

EBIT (Q3, 2018)

(61.3m)

Market capitalization (4-Dec-2018)

1.9b

Closing stock price (4-Dec-2018)

40.9

Cash (30-Sep-2018)

235.0m
Aerie Pharmaceuticals's current market capitalization is $1.9 b.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

General and administrative expense

10.3m30.6m44.5m73.6m

R&D expense

11.9m44.5m52.4m72.1m

Operating expense total

22.2m75.1m96.9m145.7m

EBIT

(22.2m)(75.1m)(96.9m)(145.7m)
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018Q2, 2018Q3, 2018

Revenue

2.4m7.3m

Cost of goods sold

59.0k205.0k

Gross profit

2.4m7.1m

Gross profit Margin, %

98%97%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

69.6m85.6m91.1m197.9m197.6m

Accounts Receivable

399.0m

Inventories

618.0k1.1m1.9m4.0m

Current Assets

70.3m141.0m138.4m237.7m254.1m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018Q2, 2018Q3, 2018

Cash

4.6m35.8m27.9m148.9m113.5m100.9m106.9m74.3m58.5m211.9m139.5m242.7m249.5m270.6m235.0m

Accounts Receivable

1.1m2.0m

Inventories

1.1m5.7m5.6m

Current Assets

7.1m65.8m57.3m171.7m171.0m159.9m156.6m120.7m108.2m256.5m210.2m310.0m341.2m295.5m246.8m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(31.1m)(48.1m)(74.4m)(99.1m)(145.1m)

Depreciation and Amortization

64.0k73.0k252.0k970.0k1.4m

Accounts Payable

2.0m551.0k

Cash From Operating Activities

(16.4m)(33.7m)(55.7m)(79.8m)(93.2m)
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018Q2, 2018Q3, 2018

Net Income

(20.9m)(6.7m)(18.5m)(31.6m)(17.2m)(36.0m)(54.0m)(22.7m)(45.9m)(69.7m)(25.8m)(54.2m)(40.7m)(95.7m)(181.1m)

Depreciation and Amortization

47.0k15.0k31.0k50.0k24.0k60.0k102.0k223.0k457.0k702.0k291.0k600.0k487.0k1.1m1.7m

Inventories

(969.0k)(5.5m)(5.3m)

Accounts Payable

1.0m208.0k1.4m2.3m(12.0k)(6.0k)2.4m(6.0k)(6.0k)(30.0k)(6.0m)
USDY, 2018

Financial Leverage

1.2 x
Show all financial metrics
Report incorrect company information

Aerie Pharmaceuticals News and Updates

Report incorrect company information

Aerie Pharmaceuticals Company Life and Culture

Report incorrect company information

Aerie Pharmaceuticals Frequently Asked Questions

  • When was Aerie Pharmaceuticals founded?

    Aerie Pharmaceuticals was founded in 2005.

  • How many employees does Aerie Pharmaceuticals have?

    Aerie Pharmaceuticals has 95 employees.

  • Who are Aerie Pharmaceuticals competitors?

    Competitors of Aerie Pharmaceuticals include Immune Therapeutics, Celyad and Alnylam Pharmaceuticals.

  • Where is Aerie Pharmaceuticals headquarters?

    Aerie Pharmaceuticals headquarters is located at 2030 Main St, Irvine.

  • Where are Aerie Pharmaceuticals offices?

    Aerie Pharmaceuticals has offices in Irvine, Dublin, Durham and Bedminster Township.

  • How many offices does Aerie Pharmaceuticals have?

    Aerie Pharmaceuticals has 4 offices.